Skip to main content

ADVERTISEMENT

health technology assessments

Research in Review
07/03/2017
JCP Editors
A tool for measuring blood flow and volume to ovarian cancer tumors accurately predicts the effectiveness of treatment, according to a recent study published in Clinical Cancer Research (June 2017;...
A tool for measuring blood flow and volume to ovarian cancer tumors accurately predicts the effectiveness of treatment, according to a recent study published in Clinical Cancer Research (June 2017;...
A tool...
07/03/2017
Journal of Clinical Pathways
Research in Review
06/22/2017
JCP Editors
Multiple prognostic tools help risk stratify older patients with multiple myeloma and predict treatment-specific survival, according to data that will be presented at the 22nd Congress of the European Hematology...
Multiple prognostic tools help risk stratify older patients with multiple myeloma and predict treatment-specific survival, according to data that will be presented at the 22nd Congress of the European Hematology...
...
06/22/2017
Journal of Clinical Pathways
Interview
03/15/2017
JCP Editors
Health care providers and research scientists frequently utilize emerging technology to enhance their ability to study diseases and develop effective treatment. A major area of growth in medicine has surrounded the...
Health care providers and research scientists frequently utilize emerging technology to enhance their ability to study diseases and develop effective treatment. A major area of growth in medicine has surrounded the...
...
03/15/2017
Journal of Clinical Pathways
News
12/12/2016
JCP Editors
IBM’s Watson for Oncology, a computer that helps oncologists make treatment decisions for individual patients, made the same recommendations 90% of the time as a team of specialist oncologists, according to a new...
IBM’s Watson for Oncology, a computer that helps oncologists make treatment decisions for individual patients, made the same recommendations 90% of the time as a team of specialist oncologists, according to a new...
IBM’s...
12/12/2016
Journal of Clinical Pathways
11/30/2016
JCP Editors
The implementation of a regret-based decision model may help patients with terminal blood cancers attain appropriate end-of-life care, according to research presented at the 2016 ASH Annual Meeting and...
The implementation of a regret-based decision model may help patients with terminal blood cancers attain appropriate end-of-life care, according to research presented at the 2016 ASH Annual Meeting and...
The...
11/30/2016
Journal of Clinical Pathways
Research in Review
10/19/2016
JCP Editors
A group of Swedish researchers may have found a cost-efficient way of examining individual leukemia cells, which could transform treatment strategies and make care more personalized, according to a study published in...
A group of Swedish researchers may have found a cost-efficient way of examining individual leukemia cells, which could transform treatment strategies and make care more personalized, according to a study published in...
A...
10/19/2016
Journal of Clinical Pathways
Research in Review
10/18/2016
JCP Editors
A review of more than 10 years of published clinical data supports the use of peptide receptor radionuclide therapy (PRRT)-containing regimens as a way of improving outcomes, minimizing toxicity, and reducing the...
A review of more than 10 years of published clinical data supports the use of peptide receptor radionuclide therapy (PRRT)-containing regimens as a way of improving outcomes, minimizing toxicity, and reducing the...
A...
10/18/2016
Journal of Clinical Pathways
Counterpoint
09/06/2016
Edward Stepanski, PhD
While the collection and reporting of patient-reported outcome data in oncology trials and care settings has yet to reach its full potential, it has made some progress in recent years. Patient-reported outcomes...
While the collection and reporting of patient-reported outcome data in oncology trials and care settings has yet to reach its full potential, it has made some progress in recent years. Patient-reported outcomes...
While...
09/06/2016
Journal of Clinical Pathways
Research in Review
05/19/2016
JCP Editors
An algorithm designed to identify patients with a risk of cancer in need of follow-up may help to reduce delays in the diagnostic evaluation of abnormal chest imaging results, according to a recent...
An algorithm designed to identify patients with a risk of cancer in need of follow-up may help to reduce delays in the diagnostic evaluation of abnormal chest imaging results, according to a recent...
An...
05/19/2016
Journal of Clinical Pathways
Research in Review
05/06/2016
JCP Editors
Results from a study evaluating different tools intended to measure patient-reported health-related quality of life (HRQoL) in patients with breast cancer suggest that the Functional Assessment of Cancer...
Results from a study evaluating different tools intended to measure patient-reported health-related quality of life (HRQoL) in patients with breast cancer suggest that the Functional Assessment of Cancer...
...
05/06/2016
Journal of Clinical Pathways